Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro
Details
The content you want to view is only available to Zendy Plus users.Already have an account? Click here. to sign in.